Cingulate

CINGNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$61.367 M

$4.22 -7.46%

Close of 6 Nov 2026

As of 6 Nov 2026, Cingulate (CING) has a market capitalization of $61.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$22.4M

Loss-making

Shares outstanding

14,541,826

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Cingulate lists more than one class of stock. Company figures above cover all classes combined.

CINGW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#313Stablecoin DevelopmentSDEV$65.7M
#314MAIA BiotechnologyMAIA$63.9M
#315CingulateCING$61.4M
#316Fortress BiotechFBIO$61.4M
#317Tenax TherapeuticsTENX$61.2M

What if Cingulate were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,941,769

Per share 460,135× higher

Bitcoin $1.53T

$105,065.76

Per share 24,897× higher

Apple $5.02T

$344,921.10

Per share 81,735× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Cingulate are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.